The stress response involves the release of certain chemicals that can disrupt normal brain activity, potentially leading to a seizure
Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract. Current Pharmaceutical Design
Conclusions This open-label, single-center pilot study suggests that GLP-1-RAs are an effective and safe treatment option for achieving significant weight loss with a favorable effect on headache, leading to reduced acetazolamide dosage in pwIIH
Advances in experimental medicine and biology, 264, 7984.
Claims about benefits are largely unproven Some weight loss programs promote microdosing to reduce nausea, stomach upset, constipation, and fatigue, which are known side effects of GLP-1 drugs
Serious reactions are rare, but an allergic reaction is possible with any injection, which is another reason a first dose in trained hands is sensible